EUVIMEDEUVIMED entdecken
Fallbericht

Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata

Yazmeen Tembunde, Chesahna Kindred

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.7782 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Yazmeen Tembunde und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Alopecia Areata, Janus Kinase Inhibitors, Nitriles, Pyrazoles. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataJanus Kinase InhibitorsNitrilesPyrazolesPyrimidinesChildHumansAdministration, CutaneousSkin CreamTreatment Outcome

Substanzen

Janus Kinase InhibitorsNitrilesPyrazolesPyrimidinesruxolitinib

Zitieren

APA

Tembunde, Y., & Kindred, C. (2024). Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7782

Vancouver

Tembunde Y, Kindred C. Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7782

BibTeX
@article{Tembunde2024,
  author = {Tembunde, Yazmeen and Kindred, Chesahna},
  title = {Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.7782}
}
Kostenlos starten →